Page 17 - Financial Statement Release News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE EU REGULATION 596/2014 ("MAR") AND ARTICLE 7 OF MAR AS INCORPORATED INTO UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN U...

Caverion Corporation's Financial Statement Release for 1 January - 31 December 2020 Strong cash flow the highlight of the corona year - enabling an increased dividend 1 October - 31 December 2020 Revenue: EUR 579.3 (589.0) million, down by 1.7 percent, 1.0 percent in local currencies. Organic growth was -5.6 percent. Services business revenue up by 4.4 percent, 5.3 percent in local currencies. Adjusted EBITA: EUR 22.5 (33.7) million, or 3.9 (5.7) percent of revenue. EBITA: EUR 6.3 (22.5) million, or 1.1 (3.8) percent of revenue, impacted by restructuring and write-downs on the last remaining ...

Investegate announcements from Aktia Bank Plc, Aktia's Financial Statement Release 2020 will be published on Thursday 18 February 2021 at 8.00 a.m.

Rapala VMC Oyj: RAPALA VMC CORPORATION'S ANNUAL ACCOUNTS 2020: COMPARABLE OPERATING PROFIT GREW FROM LAST YEAR DESPITE THE COVID-19 PANDEMIC; SUCCESSFULL AND FORCEFUL ACTIONS LED TO SIGNIFICANT REDUCTION IN INVENTORIES AND STRONG OPERATING CASH FLOW February 9, 2021 at 4:00 p.m. RAPALA VMC CORPORATION'S ANNUAL ACCOUNTS 2020: COMPARABLE OPERATING PROFIT GREW FROM LAST YEAR DESPITE THE COVID-19 PANDEMIC; SUCCESSFULL AND FORCEFUL ACTIONS LED TO SIGNIFICANT REDUCTION IN INVENTORIES AND STRONG OPERATING CASH FLOW January-December (FY) in brief: Net sales were 261.3 MEUR, down 5% from previous year...

Strong performance amid challenges brought on by COVID-19 pandemic “The COVID-19 pandemic made 2020 an exceptional and demanding year for Orion and for the world. The strong spike in demand for pharmaceuticals seen in March and April brought challenges to Orion’s production and logistics. However, we prevailed due to the strong commitment and hard work of our people. We strived successfully – and will carry on striving – to ensure that pharmaceuticals manufactured and sold by Orion continue to be available to patients. Our current inventory status is good, but we need to keep working ...